SG Americas Securities LLC lessened its holdings in Chemed Co. (NYSE:CHE) by 8.9% in the 3rd quarter, HoldingsChannel reports. The fund owned 3,966 shares of the company’s stock after selling 387 shares during the period. SG Americas Securities LLC’s holdings in Chemed were worth $1,267,000 as of its most recent SEC filing.
Other large investors have also recently made changes to their positions in the company. Laurion Capital Management LP purchased a new position in shares of Chemed in the second quarter worth about $492,000. Marshall Wace LLP purchased a new position in shares of Chemed in the second quarter worth about $1,433,000. First Trust Advisors LP raised its stake in shares of Chemed by 370.3% in the third quarter. First Trust Advisors LP now owns 81,596 shares of the company’s stock worth $26,076,000 after purchasing an additional 64,248 shares during the last quarter. Virginia Retirement Systems ET AL raised its stake in shares of Chemed by 18.1% in the third quarter. Virginia Retirement Systems ET AL now owns 91,400 shares of the company’s stock worth $29,210,000 after purchasing an additional 14,000 shares during the last quarter. Finally, US Bancorp DE raised its stake in shares of Chemed by 2.3% in the third quarter. US Bancorp DE now owns 16,755 shares of the company’s stock worth $5,355,000 after purchasing an additional 376 shares during the last quarter. Hedge funds and other institutional investors own 88.06% of the company’s stock.
Shares of NYSE:CHE opened at $302.95 on Friday. Chemed Co. has a 52-week low of $234.00 and a 52-week high of $335.99. The stock has a market capitalization of $4.90 billion, a PE ratio of 26.94, a PEG ratio of 2.68 and a beta of 1.18. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.14 and a quick ratio of 1.11.
The business also recently declared a quarterly dividend, which was paid on Monday, December 3rd. Investors of record on Monday, November 12th were given a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a yield of 0.40%. The ex-dividend date of this dividend was Thursday, November 8th. Chemed’s dividend payout ratio is currently 22.39%.
Several research analysts have recently issued reports on CHE shares. Zacks Investment Research restated a “buy” rating and issued a $342.00 price objective on shares of Chemed in a research note on Monday, November 12th. Bank of America started coverage on Chemed in a research note on Friday, October 12th. They issued a “buy” rating and a $390.00 price objective for the company. One investment analyst has rated the stock with a hold rating and four have given a buy rating to the stock. The company currently has a consensus rating of “Buy” and an average price target of $332.00.
In related news, Director Donald E. Saunders sold 300 shares of Chemed stock in a transaction that occurred on Monday, November 5th. The stock was sold at an average price of $308.74, for a total transaction of $92,622.00. Following the completion of the transaction, the director now directly owns 8,251 shares in the company, valued at $2,547,413.74. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Kevin J. Mcnamara sold 7,000 shares of Chemed stock in a transaction that occurred on Friday, November 2nd. The shares were sold at an average price of $305.98, for a total value of $2,141,860.00. Following the transaction, the insider now owns 141,293 shares of the company’s stock, valued at $43,232,832.14. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 24,953 shares of company stock valued at $7,678,463. 4.90% of the stock is owned by company insiders.
Chemed Company Profile
Chemed Corporation provides hospice and palliative care services in the United States. It operates through two segments, VITAS and Roto-Rooter. The VITAS segment offers direct medical services, as well as spiritual and emotional counseling services to terminally ill patients. This segment offers its services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers.
Recommended Story: Intrinsic Value and Stock Selection
Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Co. (NYSE:CHE).
Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.